LPCN
Price
$8.13
Change
-$0.21 (-2.51%)
Updated
Feb 4, 02:56 PM (EDT)
Capitalization
46.91M
Intraday BUY SELL Signals
LXEO
Price
$7.13
Change
-$0.40 (-5.32%)
Updated
Feb 4, 02:57 PM (EDT)
Capitalization
548.86M
40 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LPCN vs LXEO

Header iconLPCN vs LXEO Comparison
Open Charts LPCN vs LXEOBanner chart's image
Lipocine
Price$8.13
Change-$0.21 (-2.51%)
Volume$121
Capitalization46.91M
Lexeo Therapeutics
Price$7.13
Change-$0.40 (-5.32%)
Volume$290
Capitalization548.86M
LPCN vs LXEO Comparison Chart in %
LPCN
Daily Signal:
Gain/Loss:
LXEO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LPCN vs. LXEO commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LPCN is a StrongBuy and LXEO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (LPCN: $8.35 vs. LXEO: $7.52)
Brand notoriety: LPCN and LXEO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LPCN: 43% vs. LXEO: 102%
Market capitalization -- LPCN: $46.91M vs. LXEO: $548.86M
LPCN [@Biotechnology] is valued at $46.91M. LXEO’s [@Biotechnology] market capitalization is $548.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LPCN’s FA Score shows that 0 FA rating(s) are green whileLXEO’s FA Score has 0 green FA rating(s).

  • LPCN’s FA Score: 0 green, 5 red.
  • LXEO’s FA Score: 0 green, 5 red.
According to our system of comparison, LPCN is a better buy in the long-term than LXEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LPCN’s TA Score shows that 3 TA indicator(s) are bullish while LXEO’s TA Score has 6 bullish TA indicator(s).

  • LPCN’s TA Score: 3 bullish, 5 bearish.
  • LXEO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, LXEO is a better buy in the short-term than LPCN.

Price Growth

LPCN (@Biotechnology) experienced а -19.56% price change this week, while LXEO (@Biotechnology) price change was -0.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

LXEO is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXEO($549M) has a higher market cap than LPCN($46.9M). LPCN YTD gains are higher at: 3.985 vs. LXEO (-24.270). LPCN has higher annual earnings (EBITDA): -6.25M vs. LXEO (-102.69M). LXEO has more cash in the bank: 123M vs. LPCN (15.1M). LPCN has less debt than LXEO: LPCN (1.48M) vs LXEO (8.46M). LPCN has higher revenues than LXEO: LPCN (4.32M) vs LXEO (0).
LPCNLXEOLPCN / LXEO
Capitalization46.9M549M9%
EBITDA-6.25M-102.69M6%
Gain YTD3.985-24.270-16%
P/E RatioN/AN/A-
Revenue4.32M0-
Total Cash15.1M123M12%
Total Debt1.48M8.46M18%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LPCNLXEO
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LPCN
Daily Signal:
Gain/Loss:
LXEO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOAX51.300.46
+0.90%
Thornburg Global Opportunities A
MAIHX20.490.12
+0.59%
Morgan Stanley Inst Passport ovrs eq IR
KTRSX9.44-0.01
-0.11%
DWS Global Income Builder S
MACCX18.06-0.15
-0.82%
MoA Catholic Values Index Fund Class
ASLDX136.29-2.23
-1.61%
American Century Select G

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been loosely correlated with SPRY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if LPCN jumps, then SPRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
-7.33%
SPRY - LPCN
63%
Loosely correlated
-1.46%
HYFT - LPCN
43%
Loosely correlated
-3.09%
ZNTL - LPCN
36%
Loosely correlated
+12.35%
GLSI - LPCN
29%
Poorly correlated
-12.34%
LXEO - LPCN
27%
Poorly correlated
-1.57%
More

LXEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LXEO has been loosely correlated with QURE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LXEO jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LXEO
1D Price
Change %
LXEO100%
-1.57%
QURE - LXEO
43%
Loosely correlated
+12.55%
CLDX - LXEO
42%
Loosely correlated
+2.07%
CGON - LXEO
41%
Loosely correlated
-3.28%
DYN - LXEO
41%
Loosely correlated
+1.07%
SLDB - LXEO
41%
Loosely correlated
+1.71%
More